Author

Cullen L. Myers

Observed name: Cullen Myers

Institution: VenatoRx Pharmaceuticals (United States)

Observed institutions: University of Waterloo, VenatoRx Pharmaceuticals (United States), University of Guelph, McMaster University

ORCID: 0000-0002-5789-2260

Observed ORCID: 0000-0002-5789-2260

OpenAlex ID: A5043623993

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa

2019 · Jodie C. Hamrick, Jean-Denis Docquier, et al. · Antimicrobial Agents and Chemotherapy · 224

Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase

2015 · Maya A. Farha, Tomasz L. Czarny, et al. · Proceedings of the National Academy of Sciences · 102

Identification of Two Phosphate Starvation-induced Wall Teichoic Acid Hydrolases Provides First Insights into the Degradative Pathway of a Key Bacterial Cell Wall Component

2016 · Cullen L. Myers, Franco K.K. Li, et al. · Journal of Biological Chemistry · 45

Semi-synthetic analogues of thiostrepton delimit the critical nature of tail region modifications in the control of protein biosynthesis and antibacterial activity

2010 · Cullen L. Myers, Pei C. Hang, et al. · Bioorganic & Medicinal Chemistry · 37

Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases

2021 · Cassandra L. Chatwin, Jodie C. Hamrick, et al. · Antimicrobial Agents and Chemotherapy · 36

Characterization of Wall Teichoic Acid Degradation by the Bacteriophage ϕ29 Appendage Protein GP12 Using Synthetic Substrate Analogs

2015 · Cullen L. Myers, Ronald G. Ireland, et al. · Journal of Biological Chemistry · 16

Cefepime–taniborbactam and ceftibuten–ledaborbactam maintain activity against KPC variants that lead to ceftazidime–avibactam resistance

2025 · Cullen L. Myers, Annie Stevenson, et al. · Antimicrobial Agents and Chemotherapy · 13

Molecular Interactions between Thiostrepton and the TipAS Protein from Streptomyces lividans

2014 · Cullen L. Myers, Jesse Harris, et al. · ChemBioChem · 9

A cell-based approach to characterize antimicrobial compounds through kinetic dose response

2016 · Craig R. MacNair, Jonathan M. Stokes, et al. · Bioorganic & Medicinal Chemistry · 8

Functional roles inS‐adenosyl‐ l ‐methionine binding and catalysis for active site residues of the thiostrepton resistance methyltransferase

2015 · Cullen L. Myers, Emily G. Kuiper, et al. · FEBS Letters · 4

A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae

2026 · Tsuyoshi Uehara, Allison L. Zulli, et al. · Nature Microbiology · 1

Burkholderia pseudomallei PenI β-lactamase and variants are potently inhibited by taniborbactam

2025 · Maria F. Mojica, Scott A. Becka, et al. · Antimicrobial Agents and Chemotherapy · 1

A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae

2024 · Tsuyoshi Uehara, Allison L. Zulli, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Investigations of the Natural Product Antibiotic Thiostrepton from Streptomyces azureus and Associated Mechanisms of Resistance

2013 · Cullen L. Myers · UWSpace (University of Waterloo)

Works count: 14

Citation count: 497

H-index: 8

I10-index: 7